Articles by Disease (Bladder Cancer)

Cancer and Phase II Drug-Metabolizing Enzymes

Journal: Current Drug Metabolism
Volume: 4
Page: 45-58
Author(s): S. A. Sheweita and A. K. Tilmisany

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

Journal: Current Cancer Drug Targets
Volume: 3
Page: 1-19
Author(s): R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden

Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease

Journal: Current Pharmaceutical Biotechnology
Volume: 4
Page: 21-37
Author(s): C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres

Advances in Gene Therapy for Bladder Cancer

Journal: Current Gene Therapy
Volume: 3
Page: 1-11
Author(s): Akira Irie

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

Journal: Current Medicinal Chemistry
Volume: 10
Page: 267-280
Author(s): Barry G. Shearer and William J. Hoekstra

Phytoestrogens: Pharmacological and Therapeutic Perspectives

Journal: Current Drug Targets
Volume: 4
Page: 77-87
Author(s): C. Bolego, A. Poli, A. Cignarella and R. Paoletti

subject Index To Volume 3

Journal: Current Drug Targets
Volume: 4
Page: 91-93
Author(s): Bentham Science Publishers

Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer

Journal: Current Pharmaceutical Design
Volume: 9
Page: 83-94
Author(s): Ciriaco A. Piccirillo and Gerald J. Prud'homme

Identifying and Validating Oncology Therapeutic Targets in the Post- Genomics Era

Journal: Current Genomics
Volume: 4
Page: 51-61
Author(s): Jian J. Lu and Matthew V. Lorenzi

Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic

Journal: Current Drug Metabolism
Volume: 3
Page: 609-622
Author(s): Youssef Jounaidi